MSB 1.45% $1.40 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15,691 Posts.
    lightbulb Created with Sketch. 5736
    IMO this could see 60% enrolment surpassed by the end of October enabling two DSMB 30 day analysis's in the month of November - the 45% and the 60% ..... it is basically only 1.5 enrolments per hospital site between now and the end of October (21 days) - just sayin'

    60% analysis IMO will be when the overwhelming results will become evident enough to stop the trial altogether

    GLTAH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.